Naturally Splendid to Launch Cannabinoid Formulated Products

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 28, 2014) - Naturally Splendid Enterprises Ltd. (the "Company") (FRANKFURT:50N)(TSX VENTURE:NSP)(OTCQB:NSPDF) is pleased to announce that Naturally Splendid's 100% owned Colorado subsidiary, Naturally Splendid Enterprises USA Limited ("Naturally Splendid USA"), anticipates that it will be launching a commercially ready suite of hemp based cannabinoid formulated nutraceutical products in the United States in early 2015 (the "Naturally Splendid USA Products") developed by Full Spectrum Laboratories, Ltd. ("FSL"). Under the terms of a letter of intent between Naturally Splendid USA, and FSL (see news release dated October 7, 2014), Naturally Splendid USA will have a right to manufacture and sell the Naturally Splendid USA Products upon entering into the definitive license agreement with FSL.

The initial suite of Naturally Splendid USA Products will include: a) micro-encapsulated hemp oil drops with high cannabidol ("CBD") expression; b) CBD based soaps, lip balms and skin creams; and c) Hemp extracted, cannabinoid based functional beverages. Future products currently being developed include topical pain ointments, a hemp-derived CBD supplement and sun block lotions.

"The opportunity to commercialize cannabinoid formulated products in the US is rapidly expanding. The formulated cannabinoid products market in the US alone exceeded $300,000,000 US in 2013 and is anticipated to grow for the foreseeable future according to Arcview Market Research," states Company CFO Chuck Jenkins.

According to the 2013/2014 "The State of Legal Marijuana Markets - 2nd Edition" published annually by Arcview Market Research (the leading American market research firm providing quantifiable research on the United States MMJ industry) the following is true:

1. The legal American MMJ 2013 market value is assessed at $1.43 billion. The national legal market is projected to grow 64% in 2014 from current levels to $2.34 billion by the end of 2014.

2. Alternative methods of consumption, infused product manufacturing (MIPS), is approaching 25% of all related sales of legal marijuana in 2013 ($357 million) from approximately 5% first reported in 2011. This growth trend is expected to continue to expand into the foreseeable future.

3. Consumer interest in Cannabidiol (CBD)-based products is soaring. Promising CBD research and beneficial patient experience has caused demand to rise sharply. CBD supplies are limited because of legal and technological constraints, which keep prices elevated. Some companies see an enormous opportunity in attempting to solve the CBD sourcing puzzle.